Abhay Patki

925 total citations · 1 hit paper
18 papers, 729 citations indexed

About

Abhay Patki is a scholar working on Virology, Molecular Biology and Immunology. According to data from OpenAlex, Abhay Patki has authored 18 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Virology, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Abhay Patki's work include HIV Research and Treatment (9 papers), Immune Cell Function and Interaction (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Abhay Patki is often cited by papers focused on HIV Research and Treatment (9 papers), Immune Cell Function and Interaction (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Abhay Patki collaborates with scholars based in United States, Spain and Romania. Abhay Patki's co-authors include Michael M. Lederman, Donald Milligan, Ayalew Tefferi, Guozhi Gao, Éric Jourdan, Mark W. Drummond, Animesh Pardanani, Elena Mishchenko, Alessandro M. Vannucchi and Ruben A. Mesa and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Abhay Patki

18 papers receiving 717 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis

2015 340 citations Animesh Pardanani, Claire Harrison et al. JAMA Oncology profile →

Peers

Countries citing papers authored by Abhay Patki

Since Specialization

Citations

This map shows the geographic impact of Abhay Patki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhay Patki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhay Patki more than expected).

Fields of papers citing papers by Abhay Patki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhay Patki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhay Patki. The network helps show where Abhay Patki may publish in the future.

Co-authorship network of co-authors of Abhay Patki

This figure shows the co-authorship network connecting the top 25 collaborators of Abhay Patki. A scholar is included among the top collaborators of Abhay Patki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abhay Patki. Abhay Patki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	First-in-human study (FIH) of FS222, a next-generation tetravalent PD-L1/CD137 bispecific antibody: Safety, pharmacodynamics (PD), and antitumor activity in patients (pts) with advanced solid tumors including PD-1 refractory melanoma. 2024 ·Journal of Clinical Oncology ·Elena Garralda, (unknown), Guillermo de Velasco, (unknown), (unknown), (unknown), Víctor Moreno, Valentina Boni, Andrés Cervantes, Valentina Gambardella, Tudor–Eliade Ciuleanu, (unknown), Delvys Rodríguez‐Abreu, Guzmán Alonso, Laurenţia Galeş, D. H. Jones, Abhay Patki, Ignacio Melero	5
2	Open-Label Phase 2 Study Results of FS118, a LAG-3/PD-L1 Bispecific Antibody, in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma 2024 ·Blood ·Jean‐Marie Michot, Abhay Patki, (unknown), Régis Costello, (unknown), Vincent Ribrag, (unknown)	2
3	Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis breakdown → 2015 ·JAMA Oncology ·Animesh Pardanani, Claire Harrison, Jörge E. Cortes, Francisco Cervantes, Ruben A. Mesa, Donald Milligan, Tamás Masszi, Elena Mishchenko, Éric Jourdan, Alessandro M. Vannucchi, Mark W. Drummond, Mindaugas Jurgutis, Kazimierz Kuliczkowski, Emanuil Gheorghita, Francesco Passamonti, Frank Neumann, Abhay Patki, Guozhi Gao, Ayalew Tefferi	340
4	High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms 2014 ·Modern Pathology ·Olga Pozdnyakova, Kaida Wu, Abhay Patki, Scott J. Rodig, Jüergen Thiele, Robert P. Hasserjian	17
5	Effect Of Treatment With The JAK2-Selective Inhibitor Fedratinib (SAR302503) On Bone Marrow Histology In Patients With Myeloproliferative Neoplasms With Myelofibrosis 2013 ·Blood ·Catriona Jamieson, Robert P. Hasserjian, Jason Gotlib, Jörge E. Cortes, Richard M. Stone, Moshe Talpaz, Jürgen Thiele, Scott J. Rodig, Abhay Patki, Kaida Wu, Jingyang Wu, Olga Pozdnyakova	6
6	Updated results from a randomized phase II dose-ranging study of the JAK2-selective inhibitor SAR302503 in patients with myelofibrosis (MF). 2013 ·Journal of Clinical Oncology ·Animesh Pardanani, Catriona Jamieson, Nashat Gabrail, Claudia Lebedinsky, Guozhi Gao, Abhay Patki, Feng Liu, Ayalew Tefferi, Moshe Talpaz	2
7	Placebo-controlled trial of prednisone in advanced HIV-1 infection 2001 ·AIDS ·Grace A. McComsey, Christopher C. Whalen, Steven D. Mawhorter, Robert Asaad, Hernán Valdez, Abhay Patki, (unknown), K V Gopalakrishna, Leonard H. Calabrese, Michael M. Lederman	65
8	Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients 2000 ·AIDS ·Hernán Valdez, Donald D. Anthony, (unknown), Abhay Patki, Janelle R. Salkowitz, Peter S. Heeger, (unknown), Anthony B. Post, Robert Asaad, Michael M. Lederman	62
9	Preferential S Phase Entry and Apoptosis of CD4+ T Lymphocytes of HIV-1-Infected Patients after in Vitro Cultivation 2000 ·Clinical Immunology ·Abhay Patki, Steven P. Zielske, Scott F. Sieg, Michael M. Lederman	15
10	HIV infection perturbs DNA content of lymphoid cells: partial correction after ‚suppression‚ of virus replication 1999 ·AIDS ·Abhay Patki, Scott F. Purvis, Hernán Valdez, John Spritzler, Elizabeth Connick, Daniel R. Kuritzkes, Harold A. Kessler, Lawrence Fox, Marty St. Clair, Alan Landay, Michael M. Lederman	13
11	Lymphocyte Proliferation Assays May Underestimate Antigen Responsiveness in Human Immunodeficiency Virus Infection 1999 ·Clinical Immunology ·Abhay Patki, Scott F. Purvis, Howard Meyerson, Michael M. Lederman	8
12	CD4+-T-cell counts, spontaneous apoptosis, and Fas expression in peripheral blood mononuclear cells obtained from human immunodeficiency virus type 1-infected subjects 1997 ·Clinical and Diagnostic Laboratory Immunology ·Abhay Patki, (unknown), Michael M. Lederman	24
13	HIV-1 Tat Protein and Its Inhibitor Ro 24-7429 Inhibit Lymphocyte Proliferation and Induce Apoptosis in Peripheral Blood Mononuclear Cells from Healthy Donors 1996 ·Cellular Immunology ·Abhay Patki, Michael M. Lederman	26
14	Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression. 1996 ·Journal of Clinical Investigation ·Abhay Patki, Miguel E. Quiñones‐Mateu, (unknown), Belinda Yen‐Lieberman, W. Henry Boom, Elaine K. Thomas, Michael M. Lederman	39
15	Detection of apoptotic cells by selective precipitation of [3H]thymidine-labelled DNA 1996 ·Clinical and Diagnostic Laboratory Immunology ·Abhay Patki, Michael M. Lederman	4
16	HIV Type 1 Tat Protein Induces Apoptosis and Death in Jurkat Cells 1995 ·AIDS Research and Human Retroviruses ·Scott F. Purvis, James W. Jacobberger, R. Michael Sramkoski, Abhay Patki, Michael M. Lederman	68
17	Cloning and characterization of the gene for the "19 kDa" antigen of Mycobacterium bovis 1990 ·Journal of General Microbiology ·Margaret E. Collins, Abhay Patki, Sue Wall, Ann Nolan, (unknown), Martin J. Woodward, Jeremy W. Dale	23
18	Molecular cloning and expression of a xylanase gene from Cellulomonas sp. into Escherichia coli 1990 ·Applied Microbiology and Biotechnology ·Jayant Bhalerao, Abhay Patki, Mrinal Bhave, Ishant Khurana, Dileep N. Deobagkar	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact